Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01827384
Title Molecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Adavosertib + Carboplatin

Temozolomide + Veliparib

Everolimus

Trametinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.